Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.020 | None | 0.500 | 1 | 0 | 2005 | 2006 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2003 | 2018 | ||||||||
|
TNF receptor superfamily member 10a | 0.521 | 0.731 | 5.1E-15 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2005 | 2018 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.040 | None | 0.750 | 1 | 0 | 1996 | 2008 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.090 | None | 0.778 | 1 | 0 | 2003 | 2014 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 2 | 0 | 1987 | 2016 | ||||||||
|
PC4 and SFRS1 interacting protein 1 | 0.490 | 0.846 | 1.00 |
|
disease | 0.360 | None | 0.857 | 2 | 0 | 1993 | 2012 | ||||||||
|
LIM domain only 2 | 0.585 | 0.654 | 0.16 |
|
disease | 0.070 | None | 0.857 | 1 | 0 | 2004 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.080 | None | 0.875 | 1 | 0 | 1997 | 2019 | ||||||||
|
SET nuclear proto-oncogene | 0.507 | 0.808 | 1.00 |
|
disease | 0.090 | None | 0.889 | 1 | 0 | 1992 | 2019 | ||||||||
|
X-ray repair cross complementing 3 | 0.505 | 0.769 | 1.9E-10 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2002 | 2014 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2003 | 2019 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2002 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.100 | None | 0.905 | 3 | 0 | 2000 | 2014 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.928 | 1 | 0 | 1989 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.938 | 2 | 0 | 1989 | 2018 | ||||||||
|
lysine acetyltransferase 6A | 0.560 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0.939 | 2 | 0 | 1997 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.939 | 1 | 0 | 1987 | 2020 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.100 | None | 0.944 | 1 | 0 | 2000 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.800 | None | 0.945 | 6 | 0 | 2005 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 0.949 | 2 | 0 | 1994 | 2017 | ||||||||
|
C-type lectin domain family 12 member A | 0.686 | 0.346 | 2.6E-07 |
|
disease | 0.100 | None | 0.950 | 1 | 0 | 2004 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 0.952 | 2 | 0 | 2006 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 6 | 0 | 1989 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
disease | 0.100 | None | 0.957 | 2 | 0 | 1994 | 2017 |